Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

NCT01312467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Adenomatous Polyp
Colorectal Cancer
Obesity

Interventions

DRUG: metformin hydrochloride

Sponsor

National Cancer Institute (NCI)